Brief: Athira Announces Last Patient Completed LIFT-AD Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease

LeonaBio

09/07/2024 12:24

July 9 (Reuters) - Athira Pharma Inc  ATHA.O :
    * ATHIRA PHARMA ANNOUNCES LAST PATIENT COMPLETED LIFT-AD
CLINICAL
TRIAL OF FOSGONIMETON IN MILD-TO-MODERATE ALZHEIMER’S DISEASE

Source text for Eikon:  ID:nGNX288ygv 
Further company coverage:  ATHA.O 

 ((Reuters.Briefs@thomsonreuters.com;))